Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Childhood acute lymphoblastic leukemia in Norway 1992-2000].
Kolmannskog S, Flaegstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A. Kolmannskog S, et al. Among authors: glomstein a. Tidsskr Nor Laegeforen. 2007 May 31;127(11):1493-5. Tidsskr Nor Laegeforen. 2007. PMID: 17551551 Free article. Norwegian.
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, Heyman M, Kristinsson J, Nersting J, Nygaard R, Svendsen AL, Vettenranta K, Weinshilboum R; Nordic Society for Paediatric Haematology and Oncology. Schmiegelow K, et al. Blood. 2009 Jun 11;113(24):6077-84. doi: 10.1182/blood-2008-11-187880. Epub 2009 Feb 17. Blood. 2009. PMID: 19224761 Free PMC article.
Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkipernaa A, Nygaard R, Saarinen-Pihkala UM. Gustafsson G, et al. Among authors: glomstein a. Leukemia. 2000 Dec;14(12):2267-75. doi: 10.1038/sj.leu.2401961. Leukemia. 2000. PMID: 11187918
Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schrøder H, Björk O. Schmiegelow K, et al. Among authors: glomstein a. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):102-9. doi: 10.1097/00043426-199703000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9149738
Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.
Schmiegelow K, Björk O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J, Mäkipernaa A, Rosthøj S, Szumlanski C, Sørensen TM, Weinshilboum R. Schmiegelow K, et al. Among authors: glomstein a. J Clin Oncol. 2003 Apr 1;21(7):1332-9. doi: 10.1200/JCO.2003.04.039. J Clin Oncol. 2003. PMID: 12663723 Clinical Trial.
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.
Saarinen-Pihkala UM, Gustafsson G, Carlsen N, Flaegstad T, Forestier E, Glomstein A, Kristinsson J, Lanning M, Schroeder H, Mellander L; Nordic Society of Pediatric Hematology and Oncology. Saarinen-Pihkala UM, et al. Among authors: glomstein a. Pediatr Blood Cancer. 2004 Jan;42(1):8-23. doi: 10.1002/pbc.10461. Pediatr Blood Cancer. 2004. PMID: 14752789
55 results